Search Site


Answer Centre - Telephone Answering in your Company Name by an Answer Centre PA


Silence Therapeutics to make regulatory filing for lead cancer therapy

04 December 2008

Biopharmaceutical company Silence Therapeutics is planning to submit a clinical trial application (CTA) for its leading drug candidate by the end of December. The company is also in talks with several third parties over possible funding options for the new drug.

Silence specialises in RNA interference technology, which selectively “silences” genes linked to the onset of disease. The company said the decision to put forward the application for Atu027 followed a board review of progress with the drug and, in particular, consideration of recent discussions with BfArM, the German regulator for drugs and medical devices.

Atu027 is a small interfering RNA (siRNA) molecule that is being developed for the systemic treatment of cancer.

Silence anticipates commencing its Phase 1b human clinical study of Atu027 in cancer patients in 2009, provided the relevant approvals are forthcoming.

Elsewhere, Silence confirmed that it was actively considering a range of collaborations and partnerships and while these discussions progress, it was managing its cash reserves prudently in order to fund its ongoing activities.

It also confirmed that it had identified a number of new targets and indication opportunities that it intends to progress in 2009.






Headlines

31 August 2010

30 August 2010

27 August 2010

20 August 2010

18 August 2010

13 August 2010

09 August 2010

06 August 2010

30 July 2010

29 July 2010

28 July 2010

27 July 2010

26 July 2010

23 July 2010

23 July 2010

22 July 2010

21 July 2010

19 July 2010

16 July 2010

12 July 2010

09 July 2010

08 July 2010

07 July 2010

06 July 2010

05 July 2010

02 July 2010

06 May 2010

13 April 2010

24 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

19 March 2010

19 March 2010

» See all News




© SmallCapNews   |   Contact Us   |   Terms of Use   |   RSS Feeds Site by LunarSafari